Therapeutic effects of remission induction chemotherapy. (A) The overall response rate was 36.4% and the disease control rate, including NC, was 90.9%. (B) The median progression-free survival was 307 days (95% CI: 168–446 days). NC, no change; CR, complete response; PR, partial response; PD, progressive disease.